Keyword: generic drugmakers
News
20.05.2013
- Generic drugmaker Actavis, which has been the subject of takeover speculation, plans to buy specialty pharmaceutical company Warner Chilcott for $5 billion in stock. The companies...
News
11.05.2013
- The world's biggest drug makers have for years enjoyed rich premiums for their medicines in the U.S. market. Those days may be coming to an end. Companies like Pfizer and...
News
02.05.2013
- Teva Pharmaceutical Industries is banking on approval in early 2014 for a new thrice-weekly version of its multiple sclerosis treatment Copaxone to bolster sales ahead of a likely...
News
25.01.2013
- Actavis, the generic drugmaker previously known as Watson Pharmaceuticals, said on Friday that it expected earnings to rise at least 30% in 2013 as it expands globally, but its...
News
06.12.2012
- Teva Pharmaceutical Industries' new Chief Executive Jeremy Levin has promised investors it will be a very different company going forward. Next week he has to prove it. Levin's...
News
02.12.2012
- The U.S. Supreme Court on Friday agreed to consider whether generic drug manufacturers can be subjected to personal injury lawsuits that allege flaws in the design of drugs, even...
News
30.11.2012
- Teva Pharmaceutical Industries, the world's biggest maker of generic drugs, forecast profit and revenue for calendar 2013 that fell short of analysts' estimates. The Israel-based...
News
30.11.2012
- German drugmaker Bayer has filed a lawsuit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth control pill Natazia...
